CRISPR

Hand with tweezers editing DNA
Biotech

Intellia races in vivo CRISPR therapy to FDA after phase 3 win

William Blair analysts called lonvo-z a “compelling one-time option" after seeing the phase 3 data.
Nick Paul Taylor Apr 27, 2026 9:24am
Hand with tweezers editing DNA

Large-scale gene editing tool could power novel genetic meds

Mar 11, 2026 12:00pm
Small bird flying out of a cage

FDA fully releases clinical hold on Intellia CRISPR trials

Mar 2, 2026 10:55am
gene editing edit gene CRISPR

FDA illuminates new approval pathway for bespoke gene therapies

Feb 23, 2026 11:30am
gold arrow pointing upward forward

FDA frees Intellia of 1 clinical hold for CRISPR therapy

Jan 27, 2026 10:54am
Evans

Inside Beam's 'big push' for in vivo gene editing

Jan 21, 2026 7:52am